iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Gladstone Institutional Advisory LLC

Gladstone Institutional Advisory LLC lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 11.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,871 shares of the financial services provider’s stock after selling 520 shares during the period. Gladstone Institutional Advisory LLC’s holdings in iShares Biotechnology ETF were worth $512,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. SPC Financial Inc. lifted its stake in iShares Biotechnology ETF by 2.4% in the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 75 shares during the last quarter. Good Life Advisors LLC raised its holdings in shares of iShares Biotechnology ETF by 59.4% in the 3rd quarter. Good Life Advisors LLC now owns 2,666 shares of the financial services provider’s stock valued at $388,000 after purchasing an additional 993 shares in the last quarter. Optimum Investment Advisors lifted its position in shares of iShares Biotechnology ETF by 5.4% during the 3rd quarter. Optimum Investment Advisors now owns 3,186 shares of the financial services provider’s stock worth $464,000 after purchasing an additional 162 shares during the last quarter. Harbour Capital Advisors LLC grew its stake in shares of iShares Biotechnology ETF by 2.1% during the third quarter. Harbour Capital Advisors LLC now owns 5,778 shares of the financial services provider’s stock worth $827,000 after purchasing an additional 120 shares in the last quarter. Finally, Madrona Financial Services LLC increased its holdings in iShares Biotechnology ETF by 108.8% in the third quarter. Madrona Financial Services LLC now owns 3,618 shares of the financial services provider’s stock valued at $527,000 after buying an additional 1,885 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.4 %

Shares of NASDAQ IBB opened at $136.55 on Friday. The business has a 50-day moving average of $135.73 and a two-hundred day moving average of $141.03. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.